Adenosine-to-inosine (A-to-I) editing and N
6-methyladenosine (m6A) modifications are pivotal
RNA modifications with widespread functional significance in physiological
and pathological processes. Although significant effort has been dedicated
to developing methodologies for identifying and quantifying these
modifications, traditional approaches have often focused on each modification
independently, neglecting the potential co-occurrence of A-to-I editing
and m6A modifications at the same adenosine residues. This
limitation has constrained our understanding of the intricate regulatory
mechanisms governing RNA function and the interplay between different
types of RNA modifications. To address this gap, we introduced an
innovative technique called deamination-assisted reverse transcription
stalling (DARTS), specifically designed for the simultaneous quantification
of A-to-I editing and m6A at the same RNA sites. DARTS
leverages the selective deamination activity of the engineered TadA–TadA8e
protein, which converts adenosine residues to inosine, in combination
with the unique property of Bst 2.0 DNA polymerase,
which stalls when encountering inosine during reverse transcription.
This approach enables the accurate quantification of A-to-I editing,
m6A, and unmodified adenosine at identical RNA sites. The
DARTS method is remarkable for its ability to directly quantify two
distinct types of RNA modifications simultaneously, a capability that
has remained largely unexplored in the field of RNA biology. By facilitating
a comprehensive analysis of the co-occurrence and interaction between
A-to-I editing and m6A modifications, DARTS opens new avenues
for exploring the complex regulatory networks modulated by different
RNA modifications.